Page 144 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 144
Cirrhosis and its Complications: Clinical Aspects (Cont.)
P0135 IMPACT OF VASOPRESSIN AVP1A RECEPTOR GENE
POLYMORPHISMS ON MORTALITY AND RENAL FAILURE
IN PATIENTS WITH ACUTE DECOMPENSATION OF
CHRONIC LIVER DISEASE
Jelte J. Schaapman, Annarein C. Kerbert*, Johan J. van der Reijden,
Alex Amoros Navarro, Marco Pavesi, Bart van Hoek, Vicente Arroyo,
Mauro Bernardi, German Soriano, Maria-Vega Catalina, Patrica Aguilar,
Hein W. Verspaget, Minneke J. Coenraad, The Netherlands
P0136 ALFAPUMP FOR THE TREATMENT OF REFRACTORY
ASCITES IN CIRRHOTIC PATIENTS
Guido Stirnimann*, Thomas Berg, Laurent Spahr, Stefan Zeuzem,
Stuart McPherson, Frank Lammert, Jana Babatz, Victor Vargas,
Vanessa Banz, Federico Storni, Andrea De Gottardi, Switzerland
P0137 SAFETY OF BOCEPREVIR-BASED TRIPLE THERAPY
IN HCV CIRRHOTIC PATIENTS AWAITING LIVER
ePOSTERS TRANSPLANTATION. ANALYSIS FROM A FRENCH
MULTICENTER, OPEN-LABEL STUDY (ANRS HC29
BOCEPRETRANSPLANT)
Hélène Fontaine*, Marianne Maynard-Muet, Cécile Bouix,
Danielle Botta-Fridlund, Louis D’Alteroche, Filomena Conti, Georges-
Philippe Pageaux, Vincent Leroy, Sophie Métivier, Rodolphe Anty,
François Durand, Valérie Canva, Pascal Lebray, Laurent Alric,
Christophe Duvoux, Ventzislava Petrov-Sanchez, Frederik Beaulieux,
Célia Willems, Christelle Paul, Pierre Pradat, Jean-Charles Duclos-Vallée,
Didier Samuel, France
P0138 THE EFFECT OF TREATMENT FOR HEPATIC
ENCEPHALOPATHY WITH NONABSORBABLE
DISACCHARIDES ON MORBIDITY AND MORTALITY IN
PATIENTS WITH CIRRHOSIS: SYSTEMATIC REVIEW AND
META-ANALYSES
Lise Lotte Gluud*, Hendrik Vilstrup, Marsha Y. Morgan, Denmark
P0139 PATIENTS EXPERIENCING REPEATED EPISODES OF
HEPATIC ENCEPHALOPATHY HAVE INCREASING RISK OF
DEATH. A POST HOC ANALYSIS OF RIFAXIMIN-A OPEN
LABEL STUDY DATA
Christian A. Bannister, Peter Conway*, Amr Radwan,
Christopher L. Morgan, Ellen Berni, Craig J. Currie, The United Kingdom
144 The International Liver Congress™ 2015 • ILC Programme
P0135 IMPACT OF VASOPRESSIN AVP1A RECEPTOR GENE
POLYMORPHISMS ON MORTALITY AND RENAL FAILURE
IN PATIENTS WITH ACUTE DECOMPENSATION OF
CHRONIC LIVER DISEASE
Jelte J. Schaapman, Annarein C. Kerbert*, Johan J. van der Reijden,
Alex Amoros Navarro, Marco Pavesi, Bart van Hoek, Vicente Arroyo,
Mauro Bernardi, German Soriano, Maria-Vega Catalina, Patrica Aguilar,
Hein W. Verspaget, Minneke J. Coenraad, The Netherlands
P0136 ALFAPUMP FOR THE TREATMENT OF REFRACTORY
ASCITES IN CIRRHOTIC PATIENTS
Guido Stirnimann*, Thomas Berg, Laurent Spahr, Stefan Zeuzem,
Stuart McPherson, Frank Lammert, Jana Babatz, Victor Vargas,
Vanessa Banz, Federico Storni, Andrea De Gottardi, Switzerland
P0137 SAFETY OF BOCEPREVIR-BASED TRIPLE THERAPY
IN HCV CIRRHOTIC PATIENTS AWAITING LIVER
ePOSTERS TRANSPLANTATION. ANALYSIS FROM A FRENCH
MULTICENTER, OPEN-LABEL STUDY (ANRS HC29
BOCEPRETRANSPLANT)
Hélène Fontaine*, Marianne Maynard-Muet, Cécile Bouix,
Danielle Botta-Fridlund, Louis D’Alteroche, Filomena Conti, Georges-
Philippe Pageaux, Vincent Leroy, Sophie Métivier, Rodolphe Anty,
François Durand, Valérie Canva, Pascal Lebray, Laurent Alric,
Christophe Duvoux, Ventzislava Petrov-Sanchez, Frederik Beaulieux,
Célia Willems, Christelle Paul, Pierre Pradat, Jean-Charles Duclos-Vallée,
Didier Samuel, France
P0138 THE EFFECT OF TREATMENT FOR HEPATIC
ENCEPHALOPATHY WITH NONABSORBABLE
DISACCHARIDES ON MORBIDITY AND MORTALITY IN
PATIENTS WITH CIRRHOSIS: SYSTEMATIC REVIEW AND
META-ANALYSES
Lise Lotte Gluud*, Hendrik Vilstrup, Marsha Y. Morgan, Denmark
P0139 PATIENTS EXPERIENCING REPEATED EPISODES OF
HEPATIC ENCEPHALOPATHY HAVE INCREASING RISK OF
DEATH. A POST HOC ANALYSIS OF RIFAXIMIN-A OPEN
LABEL STUDY DATA
Christian A. Bannister, Peter Conway*, Amr Radwan,
Christopher L. Morgan, Ellen Berni, Craig J. Currie, The United Kingdom
144 The International Liver Congress™ 2015 • ILC Programme
